Drug treatment of hypertension: implications of ALLHAT
- PMID: 12748205
- PMCID: PMC1767664
- DOI: 10.1136/heart.89.6.589
Drug treatment of hypertension: implications of ALLHAT
References
-
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981–97. - PubMed
-
- The ALLHAT Officers and Co-ordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomly assigned to doxazosin vs chlorthalidone: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000;283:1967–75. - PubMed
-
- Appel LJ. The verdict from ALLHAT – thiazide diuretics are the preferred initial therapy for hypertension. JAMA 2002;288:3039–41. - PubMed
-
- Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–13. - PubMed
-
- Dickerson JE, Hingorani AD, Ashby MJ, et al. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999;353:2008–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical